<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200223046586N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-03-06</date_registration>
      <primary_sponsor>Shahroud University of Medical Sciences</primary_sponsor>
      <public_title>The effect of educational-supportive program on self-care of patients with heart failure and caregiver burden</public_title>
      <acronym></acronym>
      <scientific_title>The effectiveness of supportive educational program on self-care in patient with chronic heart failure and care burden in family caregiver: A parallel randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-04-02</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>64</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/46103</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: The random allocation sequence and list of blocks will be obtained by the software consultant with statistics. The https://www.sealedenvelope.com website is a useful site for generating random sequences for block type randomization. This site is designed so that there is no limit to the number of random allocation groups.The block method is used to generate random allocation sequences.Patients will be selected according to the criteria of the researcher by sequential sampling method and will be randomly divided into two groups intervention and control. Randomization will be done in secret; after obtaining informed consent, which group (intervention or control) will be randomly assigned to each patient according to the specified blocks, as the participatory education for the patient and caregiver will take place, each patient's caregiver code will also be included. The random assignment sequence is obtained by the software's statistical and statistical expert.Patients and caregivers who have the inclusion criteria are enrolled by the researcher. Participants will be assigned randomly via specified blocking to hide the random assignment of the group names in the random assignment sequence. Participants were coded in order of entry into the study and assigned to the intervention or control group, Blinding description: Due to the nature of the study and the fact that the researcher is conducting the educational intervention as well as the patient and caregiver are aware of the type of education  they receive (routine clinic education or supportive educational program) it is not possible to blind the participants and the researcher. In this study, data collectors and data analysts are blinded and not aware of how individuals are assigned to groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Heart failure.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Includes a group of patients with heart failure and caregivers who receive educational-supportive  program in three sessions including one individual training session per patient and caregiver on the first day of referral to the heart clinic and two group sessions (within two weeks) and two phone fallow up plan. The first training session includes introducing the researcher to the patient and caregiver and outlining the educational program, the content and number of sessions, and the importance of the research topic for the patient and caregiver, explaining the importance of the role of self-care in the patient, and the beneficial effects of self-care explaining and emphasizing the importance. The role of caregivers and the importance of reducing the burden of care giving and its effects on caregivers and patients is between 20 and 30 minutes, with face-to-face information focused on questions and answers. The second and third sessions will consist of group training (30-35 minutes) with the presence of patients and caregivers in groups of 6 to 8 persons. Group teaching will be delivered with PowerPoint slides, group discussion and hands-on presentation.The content of the second session will include general descriptions of heart failure, signs and symptoms, an explanation of how to properly care for yourself and its dimensions, and an explanation of the importance of how to care for and manage the patient's signs and symptoms in emergency situations and conditions. The third session includes the familiarity with the drugs and the necessity of their use and possible side effects, the importance of precise drug use in exacerbating and preventing hospitalization, the importance and necessity of making lifestyle changes for the patient and caregiver, including adherence to appropriate dietary plans, including consumption restrictions. Sodium and fluids, exercise and permitted exercise, drug compliance, smoking cessation, weight control. According to the advocacy approach of the educational program, during the face-to-face training sessions, specific needs and follow-up questions of patients and caregivers in the field of medication, diet, and physiotherapy program will be identified.  Depending on the type of need, guidance will be given on how to access the specialist to meet the needs, and during the follow-up sessions, the patient referral process and caregiver will be followed up. Intervention 2: Control group: Patients with heart failure and their caregivers are referred to the heart clinic and receive oral education and pamphlets related to the clinic.At the end of the study, an educational booklet will be provided to patients.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Part of the patient and caregiver demographic information is shared after unidentifiable individuals
All information about self-care assessment in patients and caregiver burden is shared after unidentifiable individuals

When:
Access period starts from August 2020

To whom:
Researchers and students of academic and scientific institutions

Conditions:
data for correlational studies

Where to obtain:
esmail.shariat@yahoo.com

How to obtain:
Clear explanation of the reason for the need to access the data and submit the data after two weeks

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Esmail Shariati</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 63. Alley 8. Foroughi Street</address>
        <city>shahroud</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3613733419</zip>
        <telephone>+98 23 3234 2000</telephone>
        <email>shariati.esmail@yahoo.com</email>
        <affiliation>Shahroud University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hossein Ebrahimi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>7th Square, Shahroud University of Medical Sciences, School of Nursing and Midwifery</address>
        <city>shahrood</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3614773947</zip>
        <telephone>+98 23 3239 3811</telephone>
        <email>h_ebrahimi43@yahoo.com</email>
        <affiliation>Shahroud University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>inclusion criteria of patient:                                             - Age 40 years and over                                               - Heart disease that will be diagnosed by a specialist cardiologist in the hospital.                    -Patients with heart failure are enrolled that are suitable physical condition to participate in the educational program and do not live alone and the patient has a family member to care .                  -Patients were enrolled in a study that, depending on the severity of the disease, required a specific treatment program following the pharmacological, dietary, and physical activity, ; It will focus on patients of Class II and above with EF less and equal 45 of NYHA criterion and criterion B and C of American Heart Association and American College of Cardiology.                                                          The latest clinical guideline for classification of patients with heart failure include of: Mild Heart Failure (Class II): LVEF 40-49% (mean 45%)، Moderate heart failure (grade III): LVEF rate of 30 to 39% (mean 35%) ،Severe heart failure (class IV): LVEF less than 30%
Inclusion criteria of caregiver:                           -Family caregivers who devote the most time to participating in the care of the patient and helping him / her to adapt and adhere to the educational plan.                                                                        -Have the opportunity to participate in educational sessions.                                                                       - Have at least three months of patient care experience.                                                                  -Ability to read and write.                                         -Be able to communicate.                                            - Have never attended any educational sessions before.                                                                           - The caregiver should not care for another patient other than the patient with heart failure.                         -Have the first care experience of a patient with heart failure.                                                                  - Do not suffer from psychological problems(based on the self-care statement).                                    - Not a member of the medical team.</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Exclusion criteria of patient:                                       -Known physical and mental illnesses that affect quality of life, such as dialysis or other known psychological problems, such as depression and schizophrenia, which require a particular medication or diet.                                    -Participation in previous educational programs</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I50</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Heart failure</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Includes a group of patients with heart failure and caregivers who receive educational-supportive  program in three sessions including one individual training session per patient and caregiver on the first day of referral to the heart clinic and two group sessions (within two weeks) and two phone fallow up plan. The first training session includes introducing the researcher to the patient and caregiver and outlining the educational program, the content and number of sessions, and the importance of the research topic for the patient and caregiver, explaining the importance of the role of self-care in the patient, and the beneficial effects of self-care explaining and emphasizing the importance. The role of caregivers and the importance of reducing the burden of care giving and its effects on caregivers and patients is between 20 and 30 minutes, with face-to-face information focused on questions and answers. The second and third sessions will consist of group training (30-35 minutes) with the presence of patients and caregivers in groups of 6 to 8 persons. Group teaching will be delivered with PowerPoint slides, group discussion and hands-on presentation.The content of the second session will include general descriptions of heart failure, signs and symptoms, an explanation of how to properly care for yourself and its dimensions, and an explanation of the importance of how to care for and manage the patient's signs and symptoms in emergency situations and conditions. The third session includes the familiarity with the drugs and the necessity of their use and possible side effects, the importance of precise drug use in exacerbating and preventing hospitalization, the importance and necessity of making lifestyle changes for the patient and caregiver, including adherence to appropriate dietary plans, including consumption restrictions. Sodium and fluids, exercise and permitted exercise, drug compliance, smoking cessation, weight control. According to the advocacy approach of the educational program, during the face-to-face training sessions, specific needs and follow-up questions of patients and caregivers in the field of medication, diet, and physiotherapy program will be identified.  Depending on the type of need, guidance will be given on how to access the specialist to meet the needs, and during the follow-up sessions, the patient referral process and caregiver will be followed up.</i_keyword>
      <i_keyword>Control group: Patients with heart failure and their caregivers are referred to the heart clinic and receive oral education and pamphlets related to the clinic.At the end of the study, an educational booklet will be provided to patients.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>First outcome: Assessment of self-care score of heart failure patients through the Self-Care Heart Failure Index (SCHFI) Questionnaire containing 15 questions in 3 subscales. Higher scores indicate greater self-care, scores above 70 indicate appropriate self-care. Second outcome : Caregiver burden assessment is a caregiver who is assessed through the Bartel Caregiver Inventory (CBI). The scores on this questionnaire range from zero to 96 which, given the mean total care burden scores, higher score indicates higher care burden. Timepoint: At the beginning of the study (before the intervention) and 8 weeks after the intervention. Method of measurement: Self-Care Heart Failure Index (SCHFI) / Bartel Caregiver Inventory (CBI).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahroud University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-02-28</approval_date>
        <contact_name>Research Ethics Committee of Shahroud University of Medical Science</contact_name>
        <contact_address>Shahroud, Seventh Tir Square, Shahroud University of Medical Sciences and Health Services, Vice Chancellor for Research and Technology shahroud Semnan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
